Evidence map›Paper›PMID 37635283›Full record

GuidelineThe Korean journal of internal medicine2023

Korean guidelines for the management of gout.

Jennifer Jooha Lee, Ji Soo Lee, Min Kyung Chung, Joong Kyong Ahn, Hyo-Jin Choi, Seung-Jae Hong, Chong-Hyeon Yoon, Su-Hyun Kim, Kyung-Hwan Jeong, Jong-Woo Kim and 12 more

Abstract readGuideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in The Korean journal of internal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Jennifer Jooha LeeDivision of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Ji Soo LeeDivision of Rheumatology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
Min Kyung ChungDivision of Rheumatology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
Joong Kyong AhnDivision of Rheumatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Hyo-Jin ChoiDivision of Rheumatology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Seung-Jae HongDivision of Rheumatology, Department of Internal Medicine, Kyung Hee University Hospital, School of Medicine, Kyung Hee University, Seoul, Korea.
Chong-Hyeon YoonDivision of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Su-Hyun KimDivision of Nephrology, Department of Internal Medicine, Chung-Ang University School of Medicine, Seoul, Korea.
Kyung-Hwan JeongDivision of Nephrology, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Korea.
Jong-Woo KimDepartment of Family Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Bo-Yeon KimDivision of Endocrinology & Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Jin-Ho ShinDivision of Cardiology, Department of Internal Medicine, College of Medicine, Hanyang University, Seoul, Korea.
Woo Gyu KimLights & Salt Internal Medicine, Goyang, Korea.
Soo-Young KimDepartment of Family Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
Hyun-Jung KimInstitute for Evidence-Based Medicine, Cochrane Korea, Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea.
Jeong-Soo SongDivision of Rheumatology, Department of Internal Medicine, Chung-Ang University, School of Medicine, Seoul, Korea.
Jae-Bum JunDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
Hyun-Ah ParkDepartment of Family Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Shung Chull ChaeDepartment of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea.
Bum Soon ChoiDivision of Nephrology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Tae Nyun KimDivision of Endocrinology and Metabolism, Department of Internal Medicine, Haundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
Hyun Ah KimDivision of Rheumatology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.

Funding

The Korean College of Rheumatology
6 · The paper itself

Abstract

Gout is the most common form of arthritis, with the prevalence increasing worldwide. The present treatment guidelines provide recommendations for the appropriate treatment of acute gout, management during the inter-critical period, and prevention of chronic complications. The guidelines were developed based on evidence-based medicine and draft recommendations finalized after expert consensus. These guidelines are designed to provide clinicians with clinical evidence to enable efficient treatment of gout.

Indexed as

Arthritis, GoutyGoutAsian PeopleConsensusHumansRepublic of KoreaGoutGuidelinesTreatment

Identifiers

PMID37635283
PMCPMC10493448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.